Astellas Selects Dendrite Compliance Solutions

Astellas Pharma U.S., Inc. has signed a three-year contract to outsource its sample accountability and compliance processes to Dendrite International, Inc. Dendrite’s Compliance Solutions division will manage Astellas Pharma’s reconciliation services, web-based reporting and trending services, inventory and audit services, and sales representative closeouts, enabling the Astellas’ U.S. sales force to remain compliant with Prescription Drug Marketing Act (PDMA) requirements.

“Dendrite came out on top in our evaluation of companies that could meet our immediate and long-term needs for sample management and compliance. Their reputation and capabilities are strong, and we’re confident they will continue to provide value as we progress in our relationship,” said Kathy Pettinato, associate director Sampling Operations at Astellas.

“Our compliance solutions are designed to decrease the administrative burden associated with the accountability of drug samples while enhancing compliance levels,” said Bill Buzzeo, vice president and general manager Dendrite Compliance Solutions division. “As Astellas continues to grow, it is critical for them to have the most sophisticated, yet highly intuitive sample accountability and compliance solutions available.”